{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:38:37Z","timestamp":1785782317097,"version":"3.56.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12924-0","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T02:01:44Z","timestamp":1726797704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic and immunomodulatory effects of Bojungikki-tang on cancer: a scoping review"],"prefix":"10.1186","volume":"24","author":[{"given":"Eunbyul","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Won","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Kyung","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"12924_CR1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"Global Burden of Disease Cancer Collaboration","year":"2019","unstructured":"Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5:1749\u201368.","journal-title":"JAMA Oncol"},{"key":"12924_CR2","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","volume":"38","author":"J Zugazagoitia","year":"2016","unstructured":"Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L. Current challenges in cancer treatment. Clin ther. 2016;38:1551\u201366.","journal-title":"Clin ther"},{"key":"12924_CR3","first-page":"297","volume":"4","author":"F Qi","year":"2010","unstructured":"Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, Li X-K, Tang W. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. BioSci Trends. 2010;4:297\u2013307.","journal-title":"BioSci Trends"},{"key":"12924_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5582\/bst.2021.01318","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang X, Qiu H, Li C, Cai P, Qi F. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends. 2021;15:283\u201398.","journal-title":"Biosci Trends"},{"key":"12924_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5582\/bst.2015.01019","volume":"9","author":"F Qi","year":"2015","unstructured":"Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z, Han J. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. BioSci Trends. 2015;9:16\u201334.","journal-title":"BioSci Trends"},{"key":"12924_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1751-0759-8-6","volume":"8","author":"H Okumi","year":"2014","unstructured":"Okumi H, Koyama A. Kampo medicine for palliative care in Japan. Biopsychosocial Med. 2014;8:6.","journal-title":"Biopsychosocial Med"},{"key":"12924_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.5124\/jkma.2021.64.5.326","volume":"64","author":"MA Lee","year":"2021","unstructured":"Lee MA. Current status of cancer immunotherapy with immune checkpoint inhibitors. J Korean Med Assoc. 2021;64:326\u201331.","journal-title":"J Korean Med Assoc"},{"key":"12924_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168:707\u201323.","journal-title":"Cell"},{"key":"12924_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12935-021-02407-8","volume":"22","author":"S Vafaei","year":"2022","unstructured":"Vafaei S, Zekiy AO, Khanamir RA, Zaman BA, Ghayourvahdat A, Azimizonuzi H, Zamani M. Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier. Cancer Cell Int. 2022;22:2.","journal-title":"Cancer Cell Int"},{"key":"12924_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00258","volume":"10","author":"R Park","year":"2020","unstructured":"Park R, Lopes L, Cristancho CR, Riano IM, Saeed A. Treatment-related adverse events of combination immune checkpoint inhibitors: systematic review and meta-analysis. Front Oncol. 2020;10: 258.","journal-title":"Front Oncol"},{"key":"12924_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fphar.2015.00150","volume":"6","author":"M Amitani","year":"2015","unstructured":"Amitani M, Amitani H, Sloan RA, Suzuki H, Sameshima N, Asakawa A, Nerome Y, Owaki T, Inui A, Hoshino E. The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo. Front Pharmacol. 2015;6:150.","journal-title":"Front Pharmacol"},{"key":"12924_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00917","volume":"11","author":"K Kuchta","year":"2020","unstructured":"Kuchta K, Cameron S. Phytotherapy for cachexia: Where do we stand? Front Pharmacol. 2020;11:917.","journal-title":"Front Pharmacol"},{"key":"12924_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/1534735410383170","volume":"9","author":"JS Jeong","year":"2010","unstructured":"Jeong JS, Ryu BH, Kim JS, Park JW, Choi WC, Yoon SW. Bojungikki-tang for cancer-related fatigue: a pilot randomized clinical trial. Integr Cancer Ther. 2010;9:331\u20138.","journal-title":"Integr Cancer Ther"},{"key":"12924_CR14","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2174\/092986710791111279","volume":"17","author":"A-K Yang","year":"2010","unstructured":"Yang A-K, He S-M, Liu L, Liu J-P, Qian Wei M, Zhou S-F. Herbal interactions with anticancer drugs: mechanistic and clinical considerations. Curr Med Chem. 2010;17:1635\u201378.","journal-title":"Curr Med Chem"},{"key":"12924_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ygyno.2004.12.063","volume":"97","author":"K Zhu","year":"2005","unstructured":"Zhu K, Fukasawa I, Furuno M, Inaba F, Yamazaki T, Kamemori T, Kousaka N, Ota Y, Hayashi M, Maehama T, et al. Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis. Gynecol Oncol. 2005;97:405\u20139.","journal-title":"Gynecol Oncol"},{"key":"12924_CR16","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0024-3205(01)01226-7","volume":"69","author":"S-T Kao","year":"2001","unstructured":"Kao S-T, Yeh C-C, Hsieh C-C, Yang M-D, Lee M-R, Liu H-S, Lin J-G. The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0\/G1 arrest. Life Sci. 2001;69:1485\u201396.","journal-title":"Life Sci"},{"key":"12924_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0162-3109(99)00034-X","volume":"43","author":"T Li","year":"1999","unstructured":"Li T, Tamada K, Abe K, Tada H, Onoe Y, Tatsugami K, Harada M, Kubo C, Nomoto K. The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41:Bu-Zhong-Yi-Qi-Tang). Immunopharmacology. 1999;43:11\u201321.","journal-title":"Immunopharmacology"},{"key":"12924_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pr10091683","volume":"10","author":"J Chun","year":"2022","unstructured":"Chun J, Kang HN, Yi J-M, Hong SH, Park S-M, Jeong M-K. Bojungikki-tang enhances the effect of PD-1 blockade in a syngeneic murine model of lung carcinoma. Processes. 2022;10: 1683.","journal-title":"Processes"},{"key":"12924_CR19","volume-title":"The efficacy of Bojungikki-tang as an adjunctive therapy for cancer: a systematic review and meta-analysis. Doctor of Philosophy","author":"J Kim","year":"2020","unstructured":"Kim J. The efficacy of Bojungikki-tang as an adjunctive therapy for cancer: a systematic review and meta-analysis. Doctor of Philosophy. Seoul: Kyung Hee University; 2020."},{"key":"12924_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O'malley L. Scoping studies: towards a methodological framework. International journal of social research methodology. 2005;8:19\u201332.","journal-title":"Int J Soc Res Methodol"},{"key":"12924_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, Moher D, Peters MD, Horsley T, Weeks L. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373.","journal-title":"Ann Intern Med"},{"key":"12924_CR22","first-page":"467","volume":"169","author":"MD Peters","year":"2020","unstructured":"Peters MD, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Chapter 11: scoping reviews. JBI manual for evidence synthesis. 2020;169:467\u2013473.","journal-title":"JBI Manual Evid Synthesis"},{"key":"12924_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovi\u0107 J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj. 2011;343:343.","journal-title":"Bmj"},{"key":"12924_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5582\/bst.2018.01144","volume":"12","author":"Z Wang","year":"2018","unstructured":"Wang Z, Qi F, Cui Y, Zhao L, Sun X, Tang W, Cai P. An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics. Biosci Trends. 2018;12:220\u201339.","journal-title":"Biosci Trends"},{"key":"12924_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00176","volume":"6","author":"K Yamaguchi","year":"2015","unstructured":"Yamaguchi K. Traditional Japanese herbal medicines for treatment of odontopathy. Front Pharmacol. 2015;6:176.","journal-title":"Front Pharmacol"},{"key":"12924_CR26","unstructured":"Yang XJ. Study on the mechanism of different meridian-returning and tonic formulas in the treatment of lung metastatic cancer. Master\u2019s degree: Beijing University of Chinese Medicine; 2013."},{"key":"12924_CR27","unstructured":"Hong E-H. The effects of Bojungikgi-tang(BJ-T) for hematopoietic function and weight loss in colon cancer induced mouse model. Graduate school of Kyung Hee University; 2014."},{"key":"12924_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/1472-6882-14-497","volume":"14","author":"M Ouyang","year":"2014","unstructured":"Ouyang M, Liu Y, Tan W, Xiao Y, Yu K, Sun X, Huang Y, Cheng J, RLuo R, Zhao X. Bu-zhong-yi-qi pill alleviate the chemotherapy-related fatigue in 4 T1 murine breast cancer model. BMC Complement Altern Med. 2014;14:497.","journal-title":"BMC Complement Altern Med"},{"key":"12924_CR29","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1177\/0960327115627686","volume":"35","author":"H Gou","year":"2016","unstructured":"Gou H, Gu L, Shang B, Xiong Y, Wang C. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice. Hum Exp Toxicol. 2016;35:1243\u201351.","journal-title":"Hum Exp Toxicol"},{"key":"12924_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.901563","volume":"13","author":"J Chun","year":"2022","unstructured":"Chun J, Park S-M, Yi J-M, Ha IJ, Kang HN, Jeong M-K. Bojungikki-Tang improves response to PD-L1 immunotherapy by regulating the tumor microenvironment in MC38 tumor-bearing mice. Front Pharmacol. 2022;13: 901563.","journal-title":"Front Pharmacol"},{"key":"12924_CR31","volume-title":"Toxicology for herbal medicine","author":"SD Lee","year":"2013","unstructured":"Lee SD, Park YC. Toxicology for herbal medicine. Paju: Korean Studies Information; 2013."},{"key":"12924_CR32","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.3892\/mmr.2015.4137","volume":"12","author":"T Sato","year":"2015","unstructured":"Sato T, Kita K, Sato C, Kaneda A. Hochu-ekki-to (Bu-zhong-yi-qi-tang), a herbal medicine, enhances cisplatin-induced apoptosis in HeLa cells. Mol Med Rep. 2015;12:6215\u201320.","journal-title":"Mol Med Rep"},{"key":"12924_CR33","doi-asserted-by":"publisher","first-page":"3692797","DOI":"10.1155\/2017\/3692797","volume":"2017","author":"N Yu","year":"2017","unstructured":"Yu N, Xiong Y, Wang C. Bu-Zhong-Yi-Qi Decoction, the Water Extract of Chinese Traditional Herbal Medicine, Enhances Cisplatin Cytotoxicity in A549\/DDP Cells through Induction of Apoptosis and Autophagy. Biomed Res Int. 2017;2017:3692797.","journal-title":"Biomed Res Int"},{"key":"12924_CR34","doi-asserted-by":"publisher","first-page":"7605057","DOI":"10.1155\/2021\/7605057","volume":"2021","author":"A Kiyomi","year":"2021","unstructured":"Kiyomi A, Matsuda A, Nara M, Yamazaki K, Imai S, Sugiura M. Immunological differences in human peripheral blood mononuclear cells treated with traditional Japanese herbal medicines Hochuekkito, Juzentaihoto, and Ninjin\u2019yoeito from different pharmaceutical companies. Evid Based Complement Alternat Med. 2021;2021:7605057.","journal-title":"Evid Based Complement Alternat Med"},{"key":"12924_CR35","unstructured":"Li F. Mechanism study on inhibition of laryngeal squamous cell carcinoma model based on LncRNA UCA1\/miRNA-185-5P pathway Fuzheng Exorcism. Master\u2019s degree: Luzhou: Southwest Medical University; 2022."},{"key":"12924_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104623","volume":"152","author":"R Xu","year":"2020","unstructured":"Xu R, Wu J, Zhang X, Zou X, Li C, Wang H, Yuan M, Chen M, Sun Q, Liu S. Modified Bu-zhong-yi-qi decoction synergies with 5 fluorouracile to inhibits gastric cancer progress via PD-1\/PD- L1-dependent T cell immunization. Pharmacol Res. 2020;152: 104623.","journal-title":"Pharmacol Res"},{"key":"12924_CR37","first-page":"18","volume":"3","author":"LM Zang","year":"2014","unstructured":"Zang LM. Main pharmacological effects and research progress of Bu-zhong-yi-qi decoction. Zhejiang Journal Animal Science and Veterinary Medicine. 2014;3:18\u20139.","journal-title":"Zhejiang J Animal Sci Veter Med"},{"key":"12924_CR38","first-page":"886","volume":"39","author":"JH Yu","year":"2019","unstructured":"Yu JH, Jiang Z, Long WN, Jun PL, Wang WL. Improvement of cancer-caused fatigue by Bu-zhong-yi-qi decoction. Jilin Journal of Traditional Chinese Medicine. 2019;39:886\u20139.","journal-title":"Jilin J Trad Chinese Med"},{"key":"12924_CR39","first-page":"25","volume":"40","author":"E Lee","year":"2015","unstructured":"Lee E, Choi Y, Kwak M. Effects of Bojungikki-tang extracts on improvement of fatigue and quality of life in patient with cervical cancer after concurrent chemoradiation therapy\u202f: a case. The Journal of East-West Medicine. 2015;40:25\u201334.","journal-title":"J East-West Med"},{"key":"12924_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024292","volume":"100","author":"B-J Lee","year":"2021","unstructured":"Lee B-J, Kim K-I, Choi C-W, Kim JY, Lee J-H. Long-term progression-free survival in a patient with advanced non-small-cell lung cancer treated with low-dose gefitinib and traditional herbal medicine: a case report. Medicine (Baltimore). 2021;100: e24292.","journal-title":"Medicine (Baltimore)"},{"key":"12924_CR41","first-page":"2685","volume":"31","author":"B Ning","year":"2020","unstructured":"Ning B, Li B, Hao S, Wang X. Clinical study on the treatment of cancer-related fatigue of spleen qi deficiency after surgery for non-small cell lung cancer by adding Bu-zhong-yi-qi decoction. Lishizhen Medicine and Materia Medica Research. 2020;31:2685\u20138.","journal-title":"Lishizhen Med Mater Med Res"},{"key":"12924_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.702812","volume":"8","author":"M Shimizu","year":"2021","unstructured":"Shimizu M, Takayama S, Kikuchi A, Arita R, Ono R, Ishizawa K, Ishii T. Kampo medicine treatment for advanced pancreatic cancer: A case series. Front Nutr. 2021;8: 702812.","journal-title":"Front Nutr"},{"key":"12924_CR43","doi-asserted-by":"publisher","unstructured":"A study on the efficacy and safety of Hochuekkito for anorexia of elderly gastric cancer patients. https:\/\/doi.org\/10.1002\/central\/CN-01880734\/full.","DOI":"10.1002\/central\/CN-01880734\/full"},{"key":"12924_CR44","doi-asserted-by":"publisher","unstructured":"Clinical evaluation of the efficacy and safety of Hochuekkito for fatigue in patients with myeloproliferative neoplasms. https:\/\/doi.org\/10.1002\/central\/CN-01902636\/full.","DOI":"10.1002\/central\/CN-01902636\/full"},{"key":"12924_CR45","unstructured":"Effects of Buzhongyiqi pills on appetite in patients with gastrointestinal cancer : a randomized controlled clinical research. https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-02184914\/full."},{"key":"12924_CR46","doi-asserted-by":"publisher","unstructured":"Safety and efficacy of Bojungikki-tang in advanced NSCLC patients being treated with immune checkpoint inhibitor: a pilot multicenter, randomized, placebo-controlled study.  https:\/\/doi.org\/10.1002\/central\/CN-02351983\/full.","DOI":"10.1002\/central\/CN-02351983\/full"},{"key":"12924_CR47","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jep.2014.06.012","volume":"155","author":"T-H Chao","year":"2014","unstructured":"Chao T-H, Fu P-K, Chang C-H, Chang S-N, Mao FC, Lin C-H, Evidence-based Chinese Medicine Research Group. Prescription patterns of Chinese herbal products for post-surgery colon cancer patients in Taiwan. J Ethnopharmacol. 2014;155:702\u2013708.","journal-title":"J Ethnopharmacol"},{"key":"12924_CR48","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jep.2017.10.031","volume":"213","author":"T-M Li","year":"2018","unstructured":"Li T-M, Yu Y-H, Tsai F-J, Cheng C-F, Wu Y-C, Ho T-J, Liu X, Tsang H, Lin T-H, Liao C-C, et al. Characteristics of Chinese herbal medicine usage and its effect on survival of lung cancer patients in Taiwan. J Ethnopharmacol. 2018;213:92\u2013100.","journal-title":"J Ethnopharmacol"},{"key":"12924_CR49","volume-title":"Systemic kampo learning method: modern kampo for beginners","author":"N Niimi","year":"2015","unstructured":"Niimi N. Systemic kampo learning method: modern kampo for beginners. Seoul: Cheonghong; 2015."},{"key":"12924_CR50","first-page":"34","volume":"37","author":"XW Hu","year":"2019","unstructured":"Hu XW, Li HJ, Qi YF. Exploring the treatment ideas of cancer fever based on Dongguan yin-fire theory. J Sichuan Tradit Chin Med. 2019;37:34\u20136.","journal-title":"J Sichuan Tradit Chin Med"},{"key":"12924_CR51","volume-title":"Evidence-based cancer supportive cancer with herbal medicine","author":"Y Motoo","year":"2020","unstructured":"Motoo Y. Evidence-based cancer supportive cancer with herbal medicine. Seoul: Cheonghong; 2020."},{"key":"12924_CR52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1272\/jnms.JNMS.2022_89-222","volume":"89","author":"Y Motoo","year":"2022","unstructured":"Motoo Y. Role of Kampo medicine in modern cancer therapy: towards completion of standard treatment. J Nippon Med Sch. 2022;89:139\u201344.","journal-title":"J Nippon Med Sch"},{"key":"12924_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.imr.2022.100839","volume":"11","author":"Y Motoo","year":"2022","unstructured":"Motoo Y, Cameron S. Kampo medicines for supportive care of patients with cancer: A brief review. Integr Med Res. 2022;11: 100839.","journal-title":"Integr Med Res"},{"key":"12924_CR54","unstructured":"Xu D. The clinical research of the effect of Buzhong Yiqi decoction in the treatment of Qi-blood deficiency type of cancerous fever. Guangzhou: Guangzhou University of Chinese Medicine; 2013."},{"issue":"1","key":"12924_CR55","doi-asserted-by":"publisher","first-page":"207613","DOI":"10.1155\/2014\/207613","volume":"2014","author":"AJ Lee","year":"2014","unstructured":"Lee AJ, Lee HJ, Kim JD, Jung HJ, Bae SH, Ryoo HM, Kim SG. Changes of Peripheral Blood Lymphocyte Subtypes in Patients with End Stage Cancer Administered Localized Radiotherapy and Bojungikki\u2010Tang. Evidence\u2010Based Complement Alternative Med. 2014;2014(1):207613.","journal-title":"Evid Based Complement Altern Med"},{"key":"12924_CR56","first-page":"1169","volume":"16","author":"GD Zhu","year":"2016","unstructured":"Zhu GD, Liu F, Zhu ZG, Sun QX, Xu X, Chen GP, Zhu Y. Clinical observation on the treatment of cancer-related fatigue in the interphase of chemotherapy for gastric cancer by Bu-zhong-yi-qi-tang. Mod Hosp. 2016;16:1169\u201371.","journal-title":"Mod Hosp"},{"key":"12924_CR57","first-page":"88","volume":"29","author":"YY Liu","year":"2016","unstructured":"Liu YY, Han T, Zhang SH, Chen WC, Zhang GZ, Zheng ZD, Xie XD. Clinical observation on the treatment of cancer-related fatigue in patients with advanced tumors by Bu-zhong-yi-qi-tang. Clin Misdiagnosis Mistherapy. 2016;29:88\u201391.","journal-title":"Clin Misdiagnosis Mistherapy"},{"key":"12924_CR58","first-page":"59","volume":"36","author":"H Zhang","year":"2017","unstructured":"Zhang H, Zhou YZ. An intervention study of Bu-zhong-yi-qi-tang plus reduction on thyroid cancer after surgery. Inner Mongol Journal of Traditional Chinese Medicine. 2017;36:59\u201360.","journal-title":"Inner Mongol Journal of Traditional Chinese Medicine"},{"key":"12924_CR59","first-page":"217","volume":"39","author":"ZC Chen","year":"2017","unstructured":"Chen ZC, Cai HB, Liang J. Effects of Buzhong Yiqi Decoction on cancer-related fatigue. Journal of Youjiang Medical University for Nationalities. 2017;39:217\u20139.","journal-title":"Journal of Youjiang Medical University for Nationalities"},{"key":"12924_CR60","first-page":"32","volume":"19","author":"GL Li","year":"2018","unstructured":"Li GL. Effect of Buzhong Yiqi decoction on the adverse reactions after chemotherapy of middle\u2013late stage malignant tumor. J Shanxi Coll Tradit Chin Med. 2018;19:32\u20134.","journal-title":"Journal of Shanxi College of Traditional Chinese Medicine"},{"key":"12924_CR61","first-page":"2039","volume":"33","author":"ZR Lin","year":"2018","unstructured":"Lin ZR, Pan P. Clinical observation on the treatment of cancer-related fatigue by Bu-Zhong-Yi-Qi Decoction. Guangming Journal of Chinese Medicine. 2018;33:2039\u201341.","journal-title":"Guangming Journal of Chinese Medicine"},{"key":"12924_CR62","first-page":"74","volume":"10","author":"CW Yang","year":"2018","unstructured":"Yang CW, Zhu Z, Chen YQ, Chen ZJ, Huang QG, Peng SZ. Clinical investigation on the improvement of cancer-related fatigue in patients with advanced malignant tumors by Bu-Zhong-Yi-Qi Decoction. Clinical Journal of Chinese Medicine. 2018;10:74\u20136.","journal-title":"Clinical Journal of Chinese Medicine"},{"key":"12924_CR63","first-page":"40","volume":"16","author":"YH Zheng","year":"2018","unstructured":"Zheng YH, Zhang HG. Clinical study on the treatment of cancerous fever with qi and blood deficiency by Bu-Zhong-Yi-Qi Decoction. Chinese Journal of Geriatric Care. 2018;16:40\u20132.","journal-title":"Chinese Journal of Geriatric Care"},{"key":"12924_CR64","first-page":"72","volume":"36","author":"J Chen","year":"2018","unstructured":"Chen J, Hu L, Guo T. Clinical analysis of using Buzhong Yiqi Decoction in the treatment of cancerous fever with Qi deficiency and blood. Journal of Sichuan of Traditional Chinese Medicine. 2018;36:72\u20134.","journal-title":"J Sichuan Trad Chinese Med"},{"key":"12924_CR65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/jcm8020155","volume":"6","author":"C Wang","year":"2019","unstructured":"Wang C, Ma Y. Observations on the efficacy of Bu-zhong-yi-qi decoction in the treatment of cancerous fever. Journal of Clinical Medicine Literature. 2019;6:155.","journal-title":"Journal of Clinical Medicine Literature"},{"key":"12924_CR66","first-page":"41","volume":"27","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Zhang A. Clinical observation of Buzhong Yiqi tang in treating cancerous fever. China\u2019s Naturopathy. 2019;27:41\u20132.","journal-title":"China's Naturopathy"},{"key":"12924_CR67","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fonc.2019.00294","volume":"9","author":"H Okabe","year":"2019","unstructured":"Okabe H, Kinjo Y, Obama K, Hosogi H, Hata H, Asao Y, Harada H, Manaka D, Itami A, Teramukai S, et al. A randomized phase II study of S-1 adjuvant chemotherapy with or without Hochu-ekki-to, a Japanese herbal medicine, for stage II\/III gastric cancer: the KUGC07 (SHOT) trial. Front Oncol. 2019;9:294.","journal-title":"Front Oncol"},{"key":"12924_CR68","unstructured":"Ning B. Clinical study on Jiawei Buzhong Yiqi decoction in the treatment of cancer-related fatigue after colorectal cancer. Master's degree. Taiyuan: Shanxi Provincial Institute of TCM; 2020."},{"key":"12924_CR69","first-page":"90","volume":"27","author":"W Luo","year":"2021","unstructured":"Luo W, Wang T, Xiong G-j, Li Z-w, Qian C, Yang C-y, Fan G-y, Ruan Z-l, Yu X-w, Wang R. Effect and safety of modified Buzhong Yiqitang on VEGF, IGF-1, TGF-\u03b21, and immune function in postoperative patients with non-small cell lung cancer after chemotherapy. Chinese Journal of Experimental Traditional Medical Formulae. 2021;27:90\u201395.","journal-title":"Chinese Journal of Experimental Traditional Medical Formulae."},{"key":"12924_CR70","first-page":"3663","volume":"35","author":"HY Liu","year":"2022","unstructured":"Liu HY. Exploring the effect of Bu-Zhong-Yi-Qi Decoction on cancer-related fatigue and immune function in patients with gastric cancer in the interphase of chemotherapy. J Med Theor & Prac. 2022;35:3663\u20135.","journal-title":"J Med Theor & Prac"},{"key":"12924_CR71","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/jjco\/hyac076","volume":"52","author":"Y Edahiro","year":"2022","unstructured":"Edahiro Y, Koike M, Nojiri S, Harada Y, Gotoh A, Fujibayashi K, Nishizaki Y, Yanagisawa N, Takaku T, Nitta H, et al. A pilot study examining the efficacy of hochuekkito for improving quality of life in patients with myeloproliferative neoplasms. Jpn J Clin Oncol. 2022;52:872\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"12924_CR72","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1002\/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W","volume":"53","author":"V Mor","year":"1984","unstructured":"Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky performance status scale: an examination of its reliability and validity in a research setting. Cancer. 1984;53:2002\u20137.","journal-title":"Cancer"},{"key":"12924_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.prmcm.2022.100139","volume":"4","author":"J Zhang","year":"2022","unstructured":"Zhang J, Liu X, Li X, Ying Z, Liu W. Mechanism of action of Bu Zhong Yi Qi Decoction in the treatment of chronic fatigue syndrome based on network pharmacology and molecular docking. Pharmacological Research-Modern Chinese Medicine. 2022;4: 100139.","journal-title":"Pharmacolog Res Modern Chinese Med"},{"key":"12924_CR74","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1634\/theoncologist.12-S1-22","volume":"12","author":"JL Ryan","year":"2007","unstructured":"Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist. 2007;12:22\u201334.","journal-title":"Oncologist"},{"key":"12924_CR75","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.intimp.2003.12.004","volume":"4","author":"A Kuroiwa","year":"2004","unstructured":"Kuroiwa A, Yan H, Eshita A, Naitoh S, Nagayama A. Effect of a traditional Japanese herbal medicine, Hochu-ekki-to (Bu-Zhong-Yi-Qi Tang), on immunity in elderly persons. Int Immunopharmacol. 2004;4:317\u201324.","journal-title":"Int Immunopharmacol"},{"key":"12924_CR76","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ctim.2018.07.003","volume":"40","author":"CY Wang","year":"2018","unstructured":"Wang CY, Huang HS, Su YC, Tu CY, Hsia TC, Huang ST. Conventional treatment integrated with Chinese herbal medicine improves the survival rate of patients with advanced non-small cell lung cancer. Complement Ther Med. 2018;40:29\u201336.","journal-title":"Complement Ther Med"},{"key":"12924_CR77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13020-023-00751-7","volume":"18","author":"YX Yu","year":"2023","unstructured":"Yu YX, Wang S, Liu ZN, Zhang X, Hu ZX, Dong HJ, Lu XY, Zheng JB, Cui HJ. Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions. Chin Med. 2023;18:59.","journal-title":"Chin Med"},{"key":"12924_CR78","doi-asserted-by":"crossref","unstructured":"Ko MM, Jeong MK, Choi CM, Lee SH, Chun J, Yi JM, Jang H, Lee SY. Safety and efficacy of Bojungikki-Tang in advanced NSCLC patients receiving treatment with immune checkpoint inhibitors: protocol for a multicenter, double-blind, randomized, placebo-controlled pilot trial. Int J Environ Res Public Health. 2023;20:4507.","DOI":"10.3390\/ijerph20054507"},{"key":"12924_CR79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1034\/j.1600-065X.2002.18809.x","volume":"188","author":"L Rivoltini","year":"2002","unstructured":"Rivoltini L, Carrabba M, Huber V, Castelli C, Novellino L, Dalerba P, Mortarini R, Arancia G, Anichini A, Fais S. Immunity to cancer: attack and escape in T lymphocyte\u2013tumor cell interaction. Immunol Rev. 2002;188:97\u2013113.","journal-title":"Immunol Rev"},{"key":"12924_CR80","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/sj.bjc.6602934","volume":"94","author":"K Hiraoka","year":"2006","unstructured":"Hiraoka K, Miyamoto M, Cho Y, Suzuoki M, Oshikiri T, Nakakubo Y, Itoh T, Ohbuchi T, Kondo S, Katoh H. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer. 2006;94:275\u201380.","journal-title":"Br J Cancer"},{"key":"12924_CR81","doi-asserted-by":"publisher","first-page":"896","DOI":"10.4049\/jimmunol.177.2.896","volume":"177","author":"AG Jarnicki","year":"2006","unstructured":"Jarnicki AG, Lysaght J, Todryk S, Mills KH. Suppression of antitumor immunity by IL-10 and TGF-\u03b2-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol. 2006;177:896\u2013904.","journal-title":"J Immunol"},{"key":"12924_CR82","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41590-020-0620-x","volume":"21","author":"B Diskin","year":"2020","unstructured":"Diskin B, Adam S, Cassini MF, Sanchez G, Liria M, Aykut B, Buttar C, Li E, Sundberg B, Salas RD. PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer. Nat Immunol. 2020;21:442\u201354.","journal-title":"Nat Immunol"},{"key":"12924_CR83","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41416-023-02558-7","volume":"130","author":"J Gorgulho","year":"2024","unstructured":"Gorgulho J, Roderburg C, Beier F, Bokemeyer C, Br\u00fcmmendorf TH, Loosen SH, Luedde T. Soluble lymphocyte activation gene-3 (sLAG3) and CD4\/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies. Br J Cancer. 2024;130:1013\u201322.","journal-title":"Br J Cancer"},{"key":"12924_CR84","doi-asserted-by":"publisher","first-page":"9381","DOI":"10.1038\/s41598-021-89043-4","volume":"11","author":"P-H Lee","year":"2021","unstructured":"Lee P-H, Yang T-Y, Chen K-C, Huang Y-H, Tseng J-S, Hsu K-H, Wu Y-C, Liu K-J, Chang G-C. Higher CD4\/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors. Sci Rep. 2021;11:9381.","journal-title":"Sci Rep"},{"key":"12924_CR85","doi-asserted-by":"publisher","first-page":"9469276","DOI":"10.1155\/2016\/9469276","volume":"2016","author":"L Zhu","year":"2016","unstructured":"Zhu L, Li L, Li Y, Wang J, Wang Q. Chinese herbal medicine as an adjunctive therapy for breast cancer: A systematic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine. 2016;2016:9469276.","journal-title":"Evidence-Based Complementary and Alternative Medicine"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12924-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T02:02:52Z","timestamp":1726797772000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12924-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12924"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12924-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1169"}}